Literature DB >> 1454515

Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.

G Hagen1, S Müller, M Beato, G Suske.   

Abstract

Previous analyses of the uteroglobin gene promoter revealed a GT1 box which is also found in the SV40 enhancer. The GT1 element in the context of the uteroglobin promoter is active in Ishikawa cells, a human endometrial cell line, but not in HeLa cells. Here we report the cloning by recognition site screening of two factors (SPR-1 and SPR-2) which bind to this GT1 motif. SPR-1 and SPR-2 are homologues of the transcription factor Sp1. All three proteins are closely related members of a gene family encoding proteins with very similar structural features. Like Sp1, SPR-1 and SPR-2 contain glutamine and serine/threonine rich amino acid stretches. Most significantly, the DNA binding domains of all three proteins are highly conserved and they recognize GT as well as GC boxes identically. SPR-2 mRNA is expressed ubiquitously, whereas SPR-1 transcripts are abundant in the brain but barely detectable in other organs. The possible function of these factors for the activity of the uteroglobin promoter is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454515      PMCID: PMC334381          DOI: 10.1093/nar/20.21.5519

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression.

Authors:  C Kingsley; A Winoto
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Novel upstream elements and the TATA-box region mediate preferential transcription from the uteroglobin promoter in endometrial cells.

Authors:  A Misseyanni; J Klug; G Suske; M Beato
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

3.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism.

Authors:  E Pascal; R Tjian
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

4.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

5.  The primary structure of transcription factor TFIIIA has 12 consecutive repeats.

Authors:  R S Brown; C Sander; P Argos
Journal:  FEBS Lett       Date:  1985-07-08       Impact factor: 4.124

6.  cis modification of the steroid 21-hydroxylase gene prevents its expression in the Y1 mouse adrenocortical tumor cell line.

Authors:  M Szyf; D S Milstone; B P Schimmer; K L Parker; J G Seidman
Journal:  Mol Endocrinol       Date:  1990-08

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors].

Authors:  M Nishida; K Kasahara; M Kaneko; H Iwasaki; K Hayashi
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1985-07

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes.

Authors:  J Miller; A D McLachlan; A Klug
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  122 in total

1.  Transcription from the P2 promoter of the growth hormone receptor gene involves members of the Sp transcription factor family.

Authors:  T E Adams
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

2.  Transcriptional regulation of mouse delta-opioid receptor gene.

Authors:  H C Liu; J T Shen; L B Augustin; J L Ko; H H Loh
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

Review 3.  A tale of three fingers: the family of mammalian Sp/XKLF transcription factors.

Authors:  S Philipsen; G Suske
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

4.  Differential regulation of the human nidogen gene promoter region by a novel cell-type-specific silencer element.

Authors:  M Zedlacher; M Schmoll; K Zimmermann; O Horstkorte; R Nischt
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

5.  FKLF, a novel Krüppel-like factor that activates human embryonic and fetal beta-like globin genes.

Authors:  H Asano; X S Li; G Stamatoyannopoulos
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Transcription factor Sp3 is regulated by acetylation.

Authors:  H Braun; R Koop; A Ertmer; S Nacht; G Suske
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

7.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.

Authors:  S B Kennett; A J Udvadia; J M Horowitz
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

8.  Characterization of the human liver fructose-1,6-bisphosphatase gene promoter.

Authors:  B Herzog; M Waltner-Law; D K Scott; K Eschrich; D K Granner
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

9.  Transcriptional regulation of the GluR2 gene: neural-specific expression, multiple promoters, and regulatory elements.

Authors:  S J Myers; J Peters; Y Huang; M B Comer; F Barthel; R Dingledine
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

10.  Several cis-regulatory elements control mRNA stability, translation efficiency, and expression pattern of Prrxl1 (paired related homeobox protein-like 1).

Authors:  Isabel Regadas; Mariana Raimundo Matos; Filipe Almeida Monteiro; José Luis Gómez-Skarmeta; Deolinda Lima; José Bessa; Fernando Casares; Carlos Reguenga
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.